<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Moya L</submitter><funding>Advance Queensland Industry Research Fellowship</funding><pubmed_abstract>Coronavirus disease 19 (COVID-19) has affected over 112 million people and killed more than 2.5 million worldwide. When the pandemic was declared, Spain and Italy accounted for 29% of the total COVID-19 related deaths in Europe, while most infected patients did not present severe illness. We hypothesised that shared genomic characteristics, distinct from the rest of Europe, could be a contributor factor to a poor prognosis in these two populations. To identify pathways related to COVID-19 severity, we shortlisted 437 candidate genes associated with host viral intake and immune evasion from SARS-like viruses. From these, 21 were associated specifically with clinically aggressive COVID-19. To determine the potential mechanism of viral infections, we performed signalling pathway analysis with</pubmed_abstract><journal>Genes</journal><pagination>22</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9858736</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Severe COVID-19 May Impact Hepatic Fibrosis /Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study.</pubmed_title><pmcid>PMC9858736</pmcid><pubmed_authors>Janaththani P</pubmed_authors><pubmed_authors>Suravajhala P</pubmed_authors><pubmed_authors>Farashi S</pubmed_authors><pubmed_authors>Batra J</pubmed_authors><pubmed_authors>Moya L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Severe COVID-19 May Impact Hepatic Fibrosis /Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study.</name><description>Coronavirus disease 19 (COVID-19) has affected over 112 million people and killed more than 2.5 million worldwide. When the pandemic was declared, Spain and Italy accounted for 29% of the total COVID-19 related deaths in Europe, while most infected patients did not present severe illness. We hypothesised that shared genomic characteristics, distinct from the rest of Europe, could be a contributor factor to a poor prognosis in these two populations. To identify pathways related to COVID-19 severity, we shortlisted 437 candidate genes associated with host viral intake and immune evasion from SARS-like viruses. From these, 21 were associated specifically with clinically aggressive COVID-19. To determine the potential mechanism of viral infections, we performed signalling pathway analysis with</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-04-07T21:05:12.97Z</modification><creation>2025-02-19T04:45:58.114Z</creation></dates><accession>S-EPMC9858736</accession><cross_references><pubmed>36672763</pubmed><doi>10.3390/genes14010022</doi></cross_references></HashMap>